跳到主内容Skip to content
Debunking Matrix
The claimEvidence against it: low (plausible mechanism, few human trials)

One sulforaphane pill equals a basket of broccoli

The evidence

Glucoraphanin alone relies on gut bacteria, converting anywhere from 1% to over 40%; outcome trials are small and mixed.

Why the claim spreads

Sulforaphane's mechanism really is elegant in cells and animals, and a supplement skips the chopping, waiting and light steaming. It sounds like a basket of broccoli pressed into one pill.

The mechanism, in brief

A sulforaphane supplement is really selling one step of the conversion path inside broccoli. Check which step before you buy, because it decides how much sulforaphane you end up with.

Sources (6)
  • Fahey, J. W., Wehage, S. L., Holtzclaw, W. D., Kensler, T. W., Egner, P. A., Shapiro, T. A., & Talalay, P. (2012). Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer Prevention Research, 5(4), 603-611.
  • Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., et al. (2011). Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prevention Research, 4(3), 384-395.
  • Fahey, J. W., Holtzclaw, W. D., Wehage, S. L., Wade, K. L., Stephenson, K. K., & Talalay, P. (2015). Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase. PLoS ONE, 10(11), e0140963.
  • Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proceedings of the National Academy of Sciences of the United States of America, 111(43), 15550-15555.
  • Zimmerman, A. W., Singh, K., Connors, S. L., Liu, H., Panjwani, A. A., Lee, L. C., et al. (2021). Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder. Molecular Autism, 12(1), 38.
  • Ou, J., Smith, R. C., Tobe, R. H., Lin, J., Arriaza, J., Fahey, J. W., et al. (2024). Efficacy of sulforaphane in treatment of children with autism spectrum disorder: a randomized double-blind placebo-controlled multi-center trial. Journal of Autism and Developmental Disorders, 54(2), 628-641.
Read the full mechanismOpens the atlas story at the scene that explains this claim.Watch the mechanism animation

Related debunks